SteadyMed (STDY)

[BioSpecialist]

Most Insider & Institutions paid $8.50 per share you can have it at $2.70 which is a fantastic entry point near ATL . The Biotech Selloffin last weeks created this unbelievable opportunity because this stock is still unknown to most investors .


http://finance.yahoo.com/q/it?s=STDY+Insider+Transactions

Mar 25, 2015 STARK BRIAN JAY Director 1,288,112 Indirect Acquisition (Non Open Market) at $8.50 per share. 10,948,952
Mar 25, 2015 FLYNN JAMES Beneficial Owner (10% or more) 737,555 Indirect Purchase at $8.50 per share. 6,269,217
Mar 25, 2015 GINOR RON Director 1,075,102 Indirect Acquisition (Non Open Market) at $8.50 per share. 9,138,367
Mar 25, 2015 BANK KEITHDirector 2,294,283 Indirect Acquisition (Non Open Market) at $8.50 per share. 19,501,405